Stay updated on Nivolumab with 5-azacytidine in Childhood AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.7%
    Check dated 2025-05-01T06:18:04.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-04-24T01:10:28.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The webpage has undergone significant content removal regarding a Phase I/II study of Nivolumab in pediatric patients with relapsed/refractory acute myeloid leukemia, including detailed study protocols and inclusion/exclusion criteria. The revision number has also been updated from v2.14.4 to v2.15.0.
    Difference
    52%
    Check dated 2025-04-16T20:33:13.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.4%
    Check dated 2025-04-09T14:29:39.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-03-25T15:03:34.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-03-11T06:45:54.000Z thumbnail image

Stay in the know with updates to Nivolumab with 5-azacytidine in Childhood AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.